Anam Aslam Shaikh, D.O. v. Irma M. Rodriguez

Texas Court of Appeals, 1st District (Houston)·Decided July 28, 2026·No. 01-25-00182-CV·Published

Opinion

Opinion issued July 28, 2026

In The

Court of Appeals

For The

First District of Texas

can impact blood glucose levels and result in vision loss, so careful monitoring of those glucose levels is required.

Irma Rodriguez suffers from diabetes and allegedly experienced retina detachment after Dr. Anam Aslam Shaikh, a rheumatologist, prescribed prednisone to her. Rodriguez filed a medical malpractice action against Shaikh, alleging that Shaikh’s negligence in prescribing prednisone caused her vision problems. After Shaikh objected to Rodriguez’s first expert report and the trial court limited that report “to causation only,” Rodriguez served Shaikh with two additional expert reports. Shaikh objected to the new reports and moved to dismiss the case, but the trial court overruled the objections and denied the motion to dismiss.

In one issue, Shaikh argues that the trial court erred in denying her motion to dismiss because Rodriguez’s two experts—an ophthalmologist and a critical care physician—were not qualified to opine on the standard care applicable to a rheumatologist treating a patient’s rheumatological condition, and therefore Rodriguez failed to serve an adequate expert report.

We affirm.

Background

Irma Rodriguez has type 2 diabetes and cataracts. In early 2022, she began experiencing pain in her shoulders, hand, and lower back due to a rheumatological condition called polymyalgia rheumatica. She started seeing Dr. Anam Shaikh, a

rheumatologist, in March 2022. Shaikh prescribed prednisone, a corticosteroid. Several months later, in August 2022, Rodriguez’s vision problems became more severe: her cataracts worsened, and she experienced diabetic retinopathy, leading to vision loss in one eye.

Rodriguez filed a negligence action against Shaikh. She alleged that her “diabetes had remained well-managed until the events leading to the current complaint.” But Shaikh “prescribed Prednisone without implementing the requisite adjustments in [Rodriguez’s] diabetes management plan or ensuring vigilant monitoring of blood glucose levels.” Shaikh also “failed to prescribe other non- corticosteroid medications as the first line of treatment instead of Prednisone.” As a result, “[t]his oversight led to a failure in controlling [Rodriguez’s] blood glucose levels in the context of corticosteroid therapy.” Rodriguez later amended her petition to assert that Shaikh was negligent for failing to obtain Rodriguez’s informed consent regarding the risks of prednisone, “such as increased blood sugar levels that could lead to vision loss.”

To support the lawsuit, Rodriguez filed an expert report by Dr. Matthew McMenemy, a board-certified ophthalmologist. McMenemy began his report by stating his qualifications:

I am a board-certified ophthalmologist with Lone Star Eye Care in Sugar Land, Texas, a full-service ophthalmology practice offering medical eye care, complete cataract care and LASIK Laser Vision Correction, as well as routine eye exams and a full-service optical shop.

I have extensive experience in performing cataract surgery, LASIK Laser Vision Correction, and providing glaucoma care. I have been caring for patients in the Sugar Land area for more than 20 years. I am also affiliated with Methodist Sugar Land Hospital. I received my medical degree from University of Texas Medical School and have been in practice for more than 30 years. Personally, I am very familiar with the effect that certain medications, like prednisone, can have on diabetic patients like Ms. Rodriguez, and believe I am qualified to render the opinions in this report.

McMenemy provided a summary of the care Rodriguez received. He then stated that the standard of care required a cautious approach to prescribing prednisone to a diabetic, because of the “known potential of corticosteroids to significantly impact blood glucose levels,” and required a prescribing physician to warn the patient “about these effects.” Further, the standard of care “under the circumstances (management of a diabetic patient with symptoms of RA [rheumatoid arthritis])” required a physician to “first consider medications that do not contain steroids (such as Humera or methotrexate)” and to consult with an endocrinologist before prescribing prednisone. He found a breach of the standard and concluded that “the medical mismanagement of Ms. Rodriguez’s diabetes . . . directly resulted in profound and irreversible harm to her vision.”

Shaikh objected to the report and argued that McMenemy is not qualified to talk about the standard of care, because he “treats patient’s eyes and related conditions,” unlike Shaikh, who “treats musculoskeletal diseases and systemic

autoimmune conditions.” The trial court agreed with Shaikh up to a point. The court ordered that McMenemy’s expert report would be limited to causation only.

Rodriguez then provided an amended report by McMenemy, and she submitted a supplemental report from a second expert, Dr. Alex Lechin. McMenemy’s amended report again addressed his experience with corticosteroids and diabetic patients, restating that he is “very familiar with the effect that certain corticosteroids, like prednisone, can have on diabetic patients like Ms. Rodriguez.” He also refined his opinion on the standard of care, stating that the standard required Shaikh to communicate with Rodriguez and her primary care doctor or a specialist “about the importance of monitoring blood glucose levels in the context of corticosteroid therapy.” The standard also required “careful coordination of care to ensure the patient’s blood sugar levels are being closely monitored on a regular basis,” and Shaikh, as the prescribing physician, “was responsible for ensuring that blood sugar levels were regularly monitored on a daily basis to protect the patient from adverse effects of corticosteroids.”

Next, the report by Lechin began by stating that he is board-certified in critical care, internal medicine, pulmonary medicine, and sleep medicine. His report went on to lay out his experience with prescribing corticosteroids for diabetic patients who have autoimmune diseases:

I am qualified to render opinions regarding standards of care, breach of the standard of care, and causation as it pertains to the diagnosis,

management, of diabetic patients like Irma Rodriguez. I am qualified to give these opinions based on my education, training, knowledge, and experience as a board-certified internal medicine and critical care physician with over 36 years of experience regularly treating patients requiring chronic use of corticosteroids[FN] to manage autoimmune conditions. I have for many years managed these conditions and prescribed corticosteroids for diabetic and non-diabetic patients with autoimmune diseases. I am very familiar with the standards required of a provider who prescribes corticosteroids, including requirements to coordinate care and consider alternative course of treatment to reduce the risk of side effects of corticosteroids on diabetic patients with autoimmune diseases.

Dr. Shaikh prescribed prednisone to treat polymyalgia rheumatica. This is a condition that is not exclusively managed by Rheumatologist[s] and can also be managed by primary care physicians or internal medicine specialists. Polymyalgia Rheumatica (PMR) is a common autoimmune disease, and depending on prevailing clinical practices can often fall under the purview of a generalist.

[FN: Prednisone is a corticosteroid.]

Free access — add to your briefcase to read the full text and ask questions with AI

Anam Aslam Shaikh, D.O. v. Irma M. Rodriguez, (Tex. Ct. App. 2026).

Anam Aslam Shaikh, D.O. v. Irma M. Rodriguez (Anam Aslam Shaikh, D.O. v. Irma M. Rodriguez) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Larson v. Downing
197 S.W.3d 303 (Texas Supreme Court, 2006)
McKowen v. Ragston
263 S.W.3d 157 (Court of Appeals of Texas, 2007)
Roberts v. Williamson
111 S.W.3d 113 (Texas Supreme Court, 2003)
Quinones v. Pin Ex Rel. Pin
298 S.W.3d 806 (Court of Appeals of Texas, 2009)
Broders v. Heise
924 S.W.2d 148 (Texas Supreme Court, 1996)
Dileep Puppala, M. D. v. James Reid Perry
564 S.W.3d 190 (Court of Appeals of Texas, 2018)
Benge v. Williams
548 S.W.3d 466 (Texas Supreme Court, 2018)